Back to Search Start Over

High and Moderate Intensity Aerobic Training Effects on Galectin-3, Pentraxin-3, and Several Inflammatory Mediators Levels in Type 2 Diabetic Women, a Randomized Clinical Trial

Authors :
Masoumeh Gholaman
Mandana Gholami
Mohammad Ali Azarbayjani
Hossein Abed Natanzi
Source :
Women’s Health Bulletin, Vol 8, Iss 4, Pp 238-246 (2021)
Publication Year :
2021
Publisher :
Shiraz University of Medical Sciences, 2021.

Abstract

Background: Galectin-3 and pentraxin-3 are recognized as cardiovascular risk factors, levels of which change in the pathological conditions, including type 2 diabetes. The aim of present research was to investigate the high and moderate intensity aerobic training effects on galectin-3, pentraxin-3, and some inflammatory mediators levels in type 2 diabetic women. Methods: Our study was a randomized clinical trial, conducted on the 36 type 2 diabetic women with an average age of 46.95±3.49 years old, randomly assigned to three equal groups, including control, continuous training with moderate-intensity (MICT), and high intensity interval training (HIIT) groups. Both MICT and HIIT program performed three sessions per week over a 12-week period. Training intensity in HIIT and MICT group was 90 and 60-70 percent of maximum heart rate, respectively. Blood samples at the baseline and after the 12-week training intervention were collected and the variables levels were measured via ELISA method. Repeated measures ANOVA test and Tukey post-hoc test were employed for data analysis. The research is documented in the Iranian Registry of Clinical Trials (registration number: IRCT20200729048252N1). Results: Galectin-3 levels significantly decreased in HIIT and MICT groups (p

Details

Language :
English
ISSN :
23455136 and 23829990
Volume :
8
Issue :
4
Database :
Directory of Open Access Journals
Journal :
Women’s Health Bulletin
Publication Type :
Academic Journal
Accession number :
edsdoj.6f0eb31bef9c49f5beea7f6c7d3b0b37
Document Type :
article
Full Text :
https://doi.org/10.30476/whb.2021.91832.1134